Free Trial
TSE:TR

Trillium Therapeutics (TR) Stock Price, News & Analysis

Trillium Therapeutics logo

About Trillium Therapeutics Stock (TSE:TR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
49,075 shs
Average Volume
99,071 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Troubadour Resources Inc. is a North American mineral acquisition and exploration company focused on the development of quality critical metal properties that are drill-ready with high-upside and expansion potential. Based in Vancouver, BC British Columbia, Troubadour's portfolio of strategic properties provides target-rich diversification and includes the Senneville Copper-Gold VMS project in Quebec, and the Amarillo Copper Porphyry and Texas Silver-Gold Projects in BC British Columbia. Troubadour trades on the TSX Venture Exchange under the symbol 'TR' and the OTC Market under the symbol 'TROUF'.

Receive TR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trillium Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

TR Stock News Headlines

Targeted Alpha Therapy Market 2028
Missed Nvidia? Trump’s Trade War Could Create a Bigger Winner
Missed out on Nvidia? Don’t worry — a bigger AI opportunity may be emerging right now, thanks to Trump’s newly announced tariffs. One under-the-radar U.S. semiconductor stock just gained a major edge over its foreign rivals. With demand poised to skyrocket, this chipmaker could be perfectly positioned to ride the next wave of AI growth. Shares are still flying low — but not for long.
See More Headlines

TR Stock Analysis - Frequently Asked Questions

Shares of TR stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Trillium Therapeutics investors own include Trillium Therapeutics (TRIL), Advanced Micro Devices (AMD), Cedar Fair (FUN), Mind Medicine (MindMed) (MNMD), NIO (NIO), Siyata Mobile (SYTA) and Adamis Pharmaceuticals (ADMP).

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Sugar And Confectionery Products
Sub-Industry
Food Products
Current Symbol
TSE:TR
CIK
N/A
Fax
N/A
Employees
2,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (TSE:TR) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners